John Xie
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
- Nephrology top 5%
Papers in
-
- Lung Cancer Treatments and Mutations 15
- Surgery 16
- Pancreatic function and diabetes 11
- Co-authors
- Lawrence A. Leiter (6 shared papers)Gary Meininger (9 shared papers)Dainius Balis (6 shared papers)William Canovatchel (7 shared papers)Kun‐Ho Yoon (3 shared papers)Pablo Arias (3 shared papers)William T. Cefalu (4 shared papers)Leo Niskanen (2 shared papers)
- Journals
- Annals of Oncology (5 papers)Journal of Clinical Oncology (5 papers)Journal of Thoracic Oncology (4 papers)Current Medical Research and Opinion (4 papers)Blood (3 papers)
- Partner nations
- United StatesSouth KoreaJapan
In The Last Decade
John Xie
41 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 85
- Endocrinology, Diabetes and Metabolism 1.2k
- Nephrology 139
- Pharmacology 252
- Surgery 614
- Molecular Biology 656
Countries citing papers authored by John Xie
This map shows the geographic impact of John Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Xie more than expected).
Fields of papers citing papers by John Xie
This network shows the impact of papers produced by John Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Xie. The network helps show where John Xie may publish in the future.
Co-authors
The 25 scholars most cited alongside John Xie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 non-inferiority trial Hit paper breakdown → | 2013 | 606 |
| 2 | 2014 | 189 | |
| 3 | 2015 | 111 | |
| 4 | 2015 | 101 | |
| 5 | 2014 | 96 | |
| 6 | 2020 | 77 | |
| 7 | All-trans retinoic acid with or without low dose cytosine arabinoside in acute promyelocytic leukemia. Report of 6 cases. | 1987 | 71 |
| 8 | 2020 | 56 | |
| 9 | 2016 | 55 | |
| 10 | 2016 | 53 | |
| 11 | 2020 | 32 | |
| 12 | 2016 | 27 | |
| 13 | 2017 | 21 | |
| 14 | 2006 | 21 | |
| 15 | 2017 | 21 | |
| 16 | 2016 | 18 | |
| 17 | 2021 | 18 | |
| 18 | 2020 | 16 | |
| 19 | 2012 | 13 | |
| 20 | 2021 | 12 |
About John Xie
John Xie is a scholar working on Pulmonary and Respiratory Medicine, Surgery, Oncology, Endocrinology, Diabetes and Metabolism and Molecular Biology, having authored 46 papers that have together received 1.7k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (15 papers), Diabetes Treatment and Management (14 papers), Pancreatic function and diabetes (11 papers), Colorectal Cancer Treatments and Studies (5 papers), Erythropoietin and Anemia Treatment (5 papers), Lung Cancer Research Studies (5 papers), Diabetes Management and Research (4 papers) and Metabolism, Diabetes, and Cancer (4 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.2k citations), Nephrology (139 citations), Pharmacology (252 citations), Surgery (614 citations) and Molecular Biology (656 citations). John Xie has collaborated with scholars based in United States, South Korea and Japan. Frequent co-authors include Lawrence A. Leiter, Gary Meininger, Dainius Balis, William Canovatchel, Kun‐Ho Yoon, Pablo Arias, William T. Cefalu, Leo Niskanen, Keith Usiskin and David Polidori. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Journal of Thoracic Oncology, Current Medical Research and Opinion and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.